Navigation Links
NewLink Genetics to Present Phase 2 Data on HyperAcute(R)-Pancreas Immunotherapy at the American Society of Clinical Oncology Annual Meeting
Date:5/20/2010

AMES, Iowa, May 20 /PRNewswire/ -- NewLink Genetics Corporation today announced that preliminary data from its Phase 2 clinical trial evaluating the effect of HyperAcute®-Pancreas immunotherapy in patients with resected pancreatic cancer will be presented during a poster session at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting held June 4-8, 2010 in Chicago, Illinois. A summary of the company's ASCO presentation is below.

Hyperacute immunotherapy in addition to standard adjuvant therapy for resected pancreatic cancer improves disease-free and overall survival: preliminary analysis of phase 2 data

  • General poster session: Sunday, June 6, 2010, 2:00 p.m.6:00 p.m. Central Time (CT)
  • Abstract # 54004 (poster board # 20F)
  • First Author: Dr. Jeffrey M. Hardacre, University Hospitals Case Medical Center, Cleveland, Ohio

About HyperAcute Cancer Immunotherapy

In transplants of human organs such as the kidneys or heart, recipients are at risk of rejecting donor organs because of immune system reactions directed against the foreign tissue. That immune response is dramatically stronger if non-primate organs, for example, pig hearts, are transplanted into primates, largely because lower animals express sugar molecules on their cell surfaces that are not expressed in humans. The sugar epitopes, known as alpha(1,3)-galactosyl, or alpha-Gal residues, are powerful antigens that cause a rapid, hyperacute rejection response whenever foreign tissues bearing
'/>"/>

SOURCE NewLink Genetics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NewLink Genetics Corporation Closes $7.5 Million Financing
2. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
3. Response Genetics Reports Second Quarter 2007 Financial Results
4. ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin
5. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
6. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
7. ZymoGenetics to Webcast Presentation at Two Upcoming Conferences
8. Interleukin Genetics Announces Management and Board Appointments
9. Response Genetics Announces Presentations/Webcasts at Upcoming Investor Conferences
10. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
11. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... July 25, 2014 Amgen (NASDAQ: ... declared a $0.61 per share dividend for the third ... Sept. 5, 2014, to all stockholders of record as ... About Amgen Amgen is committed to ... serious illnesses by discovering, developing, manufacturing and delivering innovative ...
(Date:7/25/2014)... University of Leicester has furthered our understanding of ... create new materials using nanosized ,building blocks,. , ... prestigious academic journal Physical Review Letters , ... rich detail the structure and internal atomic motion ... and a single helium atom. , The technique ...
(Date:7/25/2014)... 25, 2014 According to a new ... Market - Global Industry Analysis, Size, Share, Growth, Trends ... market is estimated at USD 161,056.5 million in 2014 ... 10.1% from 2014 to 2020, to reach an estimated ... biological drugs market is witnessing a significant growth due ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 The Conferee ... for Topics for Conferee Networking. These two-hour sessions provide ... to meet and resolve problems, discuss new techniques, or ... deadline to submit a topic for consideration is August ... pittcon.org . The Conferee Networking committee will review the ...
Breaking Biology Technology:Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 2Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 3Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2
... Scientists are working to develop a new drug that ... that "ages" after a person is exposed to deadly ... chemistry at The Ohio State University (OSU), is leveraging ... more effective antidote to lethal chemicals called organophosphorus (OP) ...
... concept of a microscope by removing the lens to create ... palm of a hand but powerful enough to create three-dimensional ... featured this week in the early online edition of the ... represents the first demonstration of lens-free optical tomographic imaging on ...
... therapists are delighted the members of the California Senate ... of Senate Bill 924 and its value to consumers. ... Therapy Association, will improve the health care process for ... and unnecessary costs because they have been unable to ...
Cached Biology Technology:OSU chemist developing solution to nerve agent exposure 2Optical microscope without lenses produces high-resolution 3-D images on a chip 2Optical microscope without lenses produces high-resolution 3-D images on a chip 3
(Date:7/25/2014)... Neuregulin 1 (NRG1) is a pleiotropic factor characterized ... alternative splicing of exons that confer to the ... role for both the myelination occurring during development ... the peripheral nerve: axon degeneration, axon regrowth, remyelination ... Western Australia have discovered that the soluble NRG1 ...
(Date:7/25/2014)... shows that the age girls reach puberty is influenced by ... which parent contributes the gene. This is the first ... after birth and details of this study were published today ... first period, known as menarche, is a marker for the ... the onset of menses varies between girls, is an inherited ...
(Date:7/25/2014)... first time, Spanish researchers have detected an unknown interaction ... cells are introduced into a droplet of salt water ... chloride crystallisation to create biomineralogical biosaline 3D morphologically complex ... material, bacteria are revived. The discovery was made by ... cover of the Astrobiology journal and may ...
Breaking Biology News(10 mins):Could age of first period influence development of diseases in older women? 2Bacteria manipulate salt to build shelters to hibernate 2
... embryo visualization technique developed by collaborators at the University ... the University of Utah will revolutionize the way birth ... That's the prediction of the researchers in an article ... 28, a peer-reviewed, open-access journal from the Public Library ...
... resistance, two new studies shed light on the complex ... an understanding of which could lead to new, more ... growing problem of antibiotic resistance. The studies, both of ... bacterial cells, will appear in the February 17 inaugural ...
... Dunlap, a 27-year-old newlywed in San Francisco, is just ... results of a large clinical trial in India. ... RISUG (Reversible Inhibition of Sperm Under Guidance): a reversible, ... protection after a 10-15 minute procedure. Researchers received approval ...
Cached Biology News:Technique makes it easier to see mouse embryo in all its glory 2Technique makes it easier to see mouse embryo in all its glory 3Pair of studies offer new clues to combat antibiotic resistance 2New male contraceptive clears hurdle 2New male contraceptive clears hurdle 3
... building blocks, Parker can create economical ... that are ideal for pick-and-place and ... Parker can also integrate pneumatic axes, ... ,guarding., Standard or custom configurations ...
... With its patented technology, the Lone ... of any Normally Open proportional valve available ... silent operation, provides repeatable high-speed performance, and ... performance. , Enhances system control and ...
... The OEM-EPC is the smallest electronic ... x 60 mm. Parker configured this unit ... science OEM markets. Used in carrier gas ... control, liquid dispensing, and hydro-dynamic focusing, the ...
... The VSO LF (Low Flow) offers the ... flow control for applications where control is critical ... miniature solenoid-operated valve automates the flow of gas ... Uses either DC current or pulse width modulation; ...
Biology Products: